Classifying PML risk with disease modifying therapies

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Classifying PML risk with disease modifying therapies
Authors
Keywords
Disease modifying therapy, Multiple sclerosis, Progressive multifocal leukoencephalopathy, Natalizumab, Fingolimod, Dimethyl fumarate, Rituximab
Journal
Multiple Sclerosis and Related Disorders
Volume 12, Issue -, Pages 59-63
Publisher
Elsevier BV
Online
2017-01-07
DOI
10.1016/j.msard.2017.01.006

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.